Skip to main content
Caplight Logo









Velvio GmbH

Velvio GmbH

Private
RegensburgHealthcare & Life Scienceshttps://www.velvio.com/

Company Overview

Velvio GmbH is a biotechnology company that develops antisense oligonucleotide compounds to restore organ repair functions as a treatment for orphan diseases in neurodegeneration, including amyotrophic lateral sclerosis (ALS) and idiopathic pulmonary fibrosis (IPF).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryantisense oligonucleotidesASOorphan diseaseneurodegenerative diseasebiotech startupclinical developmenttissue regenerationG-CSF therapydrug pipelinein-silico drug designcomputational biologytherapeutic compoundsbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Velvio GmbH Comparables

Compare Velvio GmbH with similar companies based on industry and business-model similarity.

Velvio GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Trace Neuroscience
81%
SynaptixBio
81%
QurAlis
78%

Velvio GmbH Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Tim-Henrik Bruun

COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors increased 93% MoM.

  • Mar 5, 2026

    Monthly visitors grew 373% MoM, reaching 667.

Velvio GmbH Filings

Explore SEC and related filing metadata, where available.

Velvio GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Velvio GmbH's valuation, stock price, and market status.

Is Velvio GmbH a public or private company?

Velvio GmbH is a private company.

What is the current stock price of Velvio GmbH?

Velvio GmbH is a private company with no public stock price. Caplight tracks Velvio GmbH's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Velvio GmbH worth (valuation)?

Valuation information for Velvio GmbH is not publicly available.

Can I buy Velvio GmbH stock?

Velvio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Velvio GmbH's last funding round?

Funding round information for Velvio GmbH is not publicly available.

Who are the main investors in Velvio GmbH?

Investor information for Velvio GmbH is not publicly disclosed.

Will Velvio GmbH IPO soon?

No public IPO plans have been announced for Velvio GmbH.

How can I track Velvio GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Velvio GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRegensburg
Employee Range2
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?